Human cell lines from families available for diabetes research
Dear Sir, Diabetes mellitus is a major health problem. In its most common form of Type 2 (non-insulin-dependent) diabetes the disease shows strong genetic determinants. Although the patterns of inheritance are unclear, this late onset disease may be caused by a dominant autosomal gene. In the less common form of diabetes, Type i (insulin-dependent) diabetes, which develops at any age but primarily affects the young, certain HLA specificities are known to provide an increased risk. These HLA determinants are necessary, but not sufficient for the disease to develop. A second or third gene for Type 1 diabetes may be necessary. In addition, rare forms of diabetes mellitus due to single point mutations in either the insulin or the insulin receptor gene have been documented. These monogenic forms of diabetes mellitus, however, hardly contribute to the overall prevalence of the disease.
Progress in understanding the patterns of inheritance of diabetes has been slow. Many scientists have attributed the lack of progress not so much to the lack of genetic markers and chromosome specific gene probes, but to the availability of families with more than one member being affected. The need for a databank of families with diabetes mellitus and of immortalized cell lines and/or DNA to be made available to researchers not only within the field of diabetes, but in any scientific discipline was voiced at the Second International Conference of Diabetes held in Monaco in the spring of 1988. The scientists' recommendation at this meeting was that such cell lines should be made available for research aimed at understanding the complex pattern of inheritance of Type 1 as well as Type 2 diabetes. The National Diabetes Advisory Board has made a similar recommendation. Recently interest has also been focussed on the fact that not all individuals with diabetes develop diabetic complications. For example, diabetic nephropathy only develops in 40-50% of affected individuals. There is data indicating that if the affected individual has a diabetic sibling or parent with this complication, the risk of developing the same complication is increased. Diabetic complications have been associated with alterations in blood pressure or blood lipids and there is increasing interest in uncovering genetic linkage or association to complications.
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The National Disease Research Interchange (NDRI) is a Philadelphia-based non-profit organization which supplies researchers with tissues and organs. An initiative h as been taken by NDRI to form the Human Biological Data Interchange (HBDI) to create a databank of families affected by diabetes. This endeavour ofHBD I has recently become successful through an effective partnership with the Juvenile Diabetes Foundation International. This organization has used its mailing list to approach their membership with questionnaires to obtain useful pedigrees for investigative purposes. As of May 1990, more than 10,000 questionnaires have been screened and a family assessment committee of the HBDI has evaluated the pedigrees to recommend Epstein-Bar virus transformations to prepare cell lines. The first catalogue of immortalized cell lines is now available in collaboration with Coriell Institute in Camden, New Jersey, USA.
The human cell lines available from the Coriell Institute are certified to be mycoplasma-free. The cells are available as liquid nitrogen frozen stock cultures. The HBDI and the Coriell Institute also plan to make DNA available.
Each family in the catalogue has been verified by HLA typing. HLA typing and clinical information will be available through HB DI. The families will remain anonymous but have agreed to be approached for additional questions. HBDI will be the medium to pass on information from the families to investigators. Since Type 1 diabetes is a disease which may develop at any age, the families will be continually followed to record if any additional member develops the disease. This information will also be made available from HBDI.
The success in preparing this first HBDI catalogue was only possible because of the generosity of NDRI, a special grant from the Juvenile Diabetes Foundation International (JDFI) and the volunteer contributions from Dr. R Rubinstein, The New York Blood Bank Center, New York who HLA-typed the families, and M. Sheehy who shared several multiplex families.
The HBDI catalogue of diabetic families will continue to grow dependent on available funds and user interest. It is planned to base the growth on questionnaires to be sent to families in 120 JDFI chapters in the USA, Canada and at least 12 other countries. HBDI welcomes proposals to initiate projects in obtaining cell lines from twins, families with both Type i and Type 2 diabetes, siblings with diabetes, three generation families, families with Type 1 diabetes in addition to other autoimmune diseases, families with several diabetic members both with and without complications, etc. Based on project proposals, HBDI will select and contact families for bleeding and subsequent EBV transformations.
We believe that the availability of these diabetes families will be of great interest to the scientific community in the promotion of studies on the genetic susceptibility to Type 1 and Type 2 diabetes and its complications. In times of reduced funding from NIH, these cell lines offer an inexpensive resource to study genetic aspects of diabetes mellitus. The bank of diabetic families is a public domain and made available to the scientific community for as a low price as possible.
Scientists interested in obtaining these cell lines for research can contact the HBDI program, National Disease Research Interchange, 2401 Walnut Street, Suite 408, Philadelphia, Pennsylvania, 19103 USA. Telephone: 215-5 57-73 61, Fax: 215-5 57-7154. 
